Tweet about this on TwitterShare on FacebookShare on LinkedIn

October 18, 2016

Bloomberg BNA
By Jacklyn Wille
October 14, 2016


A new lawsuit accuses Cigna Corp. of a fraudulent overcharging scheme that caused health plan participants to pay more than 10 times the true cost of prescription drugs in some cases ( Negron v. Cigna Corp. , D. Conn., No. 3:16-cv-01702, complaint filed 10/13/16 ).

The proposed class action, filed Oct. 13 in a Connecticut federal court, alleges that the insurer forced in-network pharmacies to overcharge patients for prescription drugs and then clawed back the unauthorized overpayments for its own benefit. In some cases, the complaint alleges, patients paid $20 for a medication that cost Cigna less than $2, with the remaining $18 kept by the insurer. Read the full article here.